Managed Account Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$440M Buy
5,939,724
+757,687
+15% +$57.9M 0.36% 71
2015
Q1
$404M Buy
5,182,037
+4,152,598
+403% +$315M 0.36% 66
2014
Q4
$74.3M Sell
1,029,439
-113,895
-10% -$7.91M 0.07% 309
2014
Q3
$70.8M Sell
1,143,334
-51,974
-4% -$3.3M 0.08% 300
2014
Q2
$76.2M Sell
1,195,308
-26,787
-2% -$1.63M 0.09% 267
2014
Q1
$75.2M Sell
1,222,095
-540,644
-31% -$31.5M 0.1% 245
2013
Q4
$101M Sell
1,762,739
-284,734
-14% -$16.1M 0.14% 183
2013
Q3
$109M Buy
2,047,473
+191,716
+10% +$10.3M 0.16% 157
2013
Q2
$95.5M Buy
+1,855,757
New +$91.7M 0.15% 167

Other funds holding MDT

Managed Account Advisors's MDT Position: Q2 2015 in Review

Managed Account Advisors increased its Medtronic (MDT) stake by 15% in Q2 2015, buying an estimated $57.9M and bringing the position to 5,939,724 shares worth $440M. The position accounts for 0.36% of the portfolio, ranked #71.

Managed Account Advisors first reported a position in MDT in Q2 2013 and has held it in 9 quarters since. 1,261 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

  • Managed Account Advisors held 5,939,724 shares of Medtronic worth $440M as of Q2 2015.
  • Managed Account Advisors bought 757,687 Medtronic shares in Q2 2015, an estimated $57.9M.
  • Medtronic made up 0.36% of Managed Account Advisors's portfolio in Q2 2015, its #71 holding.
  • Managed Account Advisors first reported a position in Medtronic in Q2 2013 and has held it in 9 quarters since.
  • 1,261 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.